Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$110,568,478
+$60,859,695 QoQ
Shares Held
2,306,393
+70.5% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. NVO ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,568,478 | 2,306,393 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $49,708,783 | 1,352,620 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $509,681,494 | 10,017,325 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $781,043,445 | 14,075,391 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $962,218,861 | 13,941,160 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $668,910,796 | 9,632,932 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $862,082,459 | 10,021,884 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,135,112,871 | 17,931,577 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,782,665,196 | 19,494,642 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,260,394,942 | 17,604,322 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,310,010,624 | 12,663,225 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,098,327,938 | 12,077,501 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $877,585,800 | 5,422,887 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $792,754,953 | 4,981,494 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $564,332,609 | 4,169,740 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $64,965,632 | 652,069 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $78,291,273 | 702,605 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $69,965,274 | 630,034 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $60,732,224 | 542,252 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $45,666,291 | 475,641 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $33,627,119 | 401,422 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $25,994,724 | 385,564 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $25,233,380 | 361,251 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $24,449,703 | 352,149 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,320,624 | 340,877 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $27,236,827 | 452,439 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||